Christian Ottmann
Company: Ambagon Therapeutics Inc
Job title: Founder & Chief Technology Officer
Seminars:
Interrogating the Protein-Protein Interface to Leverage the Bottom-Up Development of Molecule Glues Irrespective of a Defined Target Protein 11:30 am
day: Day One
Panel Discussion: Envisioning the Rational Design of Molecular Glues to Generate Clinically Relevant Candidates with High Value Therapeutic Applications 9:00 am
day: Day One